Cargando…
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
Autores principales: | Siegel, Corey A, Melmed, Gil Y, McGovern, Dermot PB, Rai, Victoria, Krammer, Florian, Rubin, David T, Abreu, Maria T, Dubinsky, Marla C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818789/ https://www.ncbi.nlm.nih.gov/pubmed/33472895 http://dx.doi.org/10.1136/gutjnl-2020-324000 |
Ejemplares similares
-
Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic
por: Melmed, Gil Y., et al.
Publicado: (2021) -
Reply
por: Melmed, Gil, et al.
Publicado: (2021) -
Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease
por: Li, Dalin, et al.
Publicado: (2021) -
Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist Consultation
por: Scott, Frank I, et al.
Publicado: (2022) -
Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Honvo, Germain, et al.
Publicado: (2019)